A multicenter Phase III study of GB232 in patients with autoimmune disorder
Latest Information Update: 03 Jan 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Autoimmune disorders
- Focus Therapeutic Use
- 03 Jan 2017 New trial record
Latest Information Update: 03 Jan 2017